
Currently in LERMIT LabEx
Organigram of LabEx LERMIT
Steering committee
A Steering Committee makes decisions as to the actions to be carried out, particularly regarding financing and change in composition of LERMIT. It is composed of members designated by the institutional partners.
Directory Board |
|
FISCHMEISTER Rodolphe |
BONNAFFE David |
Full members |
Substitute members |
JUNOT Christophe |
DORIS Eric |
CHERFILS Jacqueline |
DAUTRY François |
HUMBERT Marc |
MARIETTE Xavier |
DEUTSCH Eric |
HEIDMANN Thierry |
FIGADÈRE Bruno |
FATTAL Elias |
NAAS Thierry |
NAHMIAS Clara |
GUITTET Eric |
GUILLOU Catherine |
PALLARDY Marc |
POUPON Erwan |
LESIEUR Sylviane |
MAILLERE Bernard |
REGNAULT Armelle |
|
LERMIT council
A LERMIT council composed of representatives of the partner laboratories will be consulted on any major issue prior to decision making by the Steering Committee.
BONNAFFE David | Directory board |
FISCHMEISTER Rodolphe | Directory board |
AMBROISE Yves | Frédéric Joliot Life Sciences Institute - CEA DRF Joliot SBCM |
CINTRAT Jean-Christophe | Frédéric Joliot Sciences Institute - CEA DRF Joliot SCBM |
GILLET Daniel | Frédéric Joliot Sciences Institute - CEA DRF Joliot SIMOPRO |
SERVENT Denis | Frédéric Joliot Life Sciences Institute - CEA DRF Joliot SIMOPRO |
ALAMI Mouad | UMR 8076 |
ONGERI Sandrine | UMR 8076 |
AROCK Michel | UMR 8113 |
ZEGHOUF Mahel | UMR 8113 |
DEWANNIEUX Marie | UMR 8122 |
BLONSKI Casimir | UMR 8182 |
LE NARVOR Christine | UMR 8182 |
BOUCHEMAL Kawthar |
UMR 8612 |
ROSILIO Véronique | UMR 8612 |
NOCTURNE Gaétane | UMR 1184 (ex UMR 1012) |
PERFETTINI Jean-Luc | UMR 1030 |
MODJTAHEDI Nazanine | UMR 1030 |
BRENNER Catherine | UMR 1180 (ex UMR 769) |
MOREL Eric | UMR 1180 (ex UMR 769) |
DORTET Laurent | EA 7361 (ex UMR 914) |
CHAUCHEREAU Anne | UMR 981 |
TELERMAN Adam | UMR 981 |
CASSARD-DOULCIER Anne-Marie | UMR 996 |
BALABANIAN Karl | UMR 996 |
COHEN-KAMINSKY Sylvia | UMR 999 |
GUIGNABERT Christophe | UMR 999 |
DUBOIS Joëlle | UPR 2301 |
IORGA Bogdan | UPR 2301 |
PRUVOST Alain |
Frédéric Joliot Life Sciences Institute - CEA DRF Joliot SPI |
SIMON Stéphanie | Frédéric Joliot Life Sciences Institute - CEA DRF Joliot SPI |
International Scientific Committee (ISC)
An International Scientific Committee, composed exclusively of outside members (8 experts, mostly from outside France, with representatives from pharmaceutical industry), will propose research orientations and be involved in decisions pertaining to changes in the composition of LERMIT and new pluridisciplinary projects. Members of this committee were nominated following a proposal made by the Steering Committee. The International Scientific Committee will also provide a regular assessment on the achievement and objectives of LERMIT.
Members
Prof. André TARTAR (France)
Faculté de Pharmacie de Lille
Keywords : Medicinal Chemistry, Drug discovery, Drug development strategy, Biotechnology, Peptide drugs
Prof. Ralph SCHERMULY (Germany)
Chair for Pulmonary Pharmacotherapy; Justus-Liebig-University Giessen
http://uglc.de/cv/schermuly
Keywords : Pulmonary circulation, Heart hypertrophy, Cell and molecular biology, Fibrosis, Cellular signalling
Prof. Andreas KUNGL (Austria)
Institute of Pharmaceutical Sciences, University of Graz
http://pharmazie.uni-graz.at/en/research/pharmaceutical-chemistry/biopharmaceuticals-and-proteomics/
Keywords : protein-ligand interactions, glycobiology, drug profiling, assay development.
Prof. Claus Michael LEHR (Germany)
Helmholtz Institute for Pharmaceutical Research Saarland (HIPS)
www.uni-saarland.de
Keywords : skin, lung and oral drug delivery, nucleotide delivery, in-vitro models of epithelial barriers, nanomedicine and nanotoxicology, nanoparticles,
Prof. Sian E. HARDING (England)
Head, Myocardial Function Section Professor of Cardiac Pharmacology NHLI, Imperial College
www1.imperial.ac.uk
Keywords : Cell signalling, Cardiovascular Pharmacology, Heart diseases, Cyclic nucleotides, membrane receptors.
Dr François BALLET (France)
Chairman of the R&D Board Medicen Paris Region
Keywords : drug discovery and development, toxicology, clinical safety, drug induced liver injury
Prof. Kevin J. HARRINGTON (England)
Reader in Biological Cancer Therapies Team Leader, Targeted Therapy Team The Institute of Cancer Research London
www.icr.ac.uk
Keywords : Oncology, clinic, gene therapy, oncolytic virotherapy, combined therapy
Prof. Marie-Cécile PLOY (France)
Head of Microbiology Department in CHU Limoges, Head of the INSERM research unit U1092 and full professor at the University of Limoges
http://www.unilim.fr/
Keywords : Antibiotic, resistance, gene transfer, integrons, new targets
Prof. Josep Samitier (Spain)
Institute for Bioengineering of Catalonia (IBEC)
http://www.ibecbarcelona.eu/member/?empID=3
Keywords: Nanomedicine, point-of-care diagnostic, biomaterials, organ-on-chip, DNA biosensors
Projects groups
EDUCATION
Members :
Pr. Marc Pallardy - UMR-S 996
Dr. Rodolphe Fischmeister - UMR-S 1180 (ex 769)
Pr. David Bonnaffé - UMR 8182
Dr. Catherine Brenner - UMR-S 1180 (ex 769)
Pr. Erwan Poupon - UMR 8076
Dr. Elias Fattal - UMR 8612
Dr. Thierry Naas - EA 7361 (ex UMR-S 914)
Dr. François Ballet - Medicen
Project CALLS
New team and new research project
Members :
Dr. Sylvia Cohen-Kaminsky - UMR-S 999
Dr. Nicolas Tsapis - UMR 8612
Dr. Françoise Bachelerie - UMR-S 996
Dr. Thierry Heidmann - UMR 8122
Dr. Rodolphe Fischmeister - UMR-S 1180 (ex UMR-S 769)
Dr. Catherine Guillou - UPR 2301
Dr. Vincent Dive - Fréféric Joliot Life Sciences Institute - CEA DRF Joliot SIMOPRO
Pr. David Bonnaffé - UMR 8182
Dr. Jean-Luc Perfettini - UMR-S 1030
Dr. Gaëlle Cuzon - EA 7361
RESEARCH
TARGET
Pr. Jean-Daniel-Brion - UMR 8076
Dr. Mouad Alami - UMR 8076
resistance
Dr. Bernard Maillère - Frédéric Joliot Life Sciences Institute - CEA DRF Joliot SIMOPRO
Pr. Sandrine Ongeri - UMR 8076
Delivery
Pr. Elias Fattal - UMR 8612
Dr. Vincent Dive - Frédéric Joliot Life Sciences instute - CEA DRF Joliot SIMOPRO
VALORISATION
GMED: Groupe "Maturation, Early Drugability"
Sylviane LESIEUR (UMR 8612: Partner 16)
(delivery, nanoparticles, imaging...)
Marc PALLARDY (UMR-S 996: Partner 3)
( toxicology and reglementary affairs....)
Jean-Daniel BRION (UMR 8076: Partner15)
(medicinal chemistry, with big pharma experience...)
Bernard MAILLERE (Frédéric Joliot Life Sciences Institute - CEA DRF Joliot SIMOPRO Partner 11)
(therapeutic protein development...)
Serge MIGNANI (Consultat)
(expert in medicinal chemistry, ex-Sanofi: Head of the Medicinal Chemistry Department and Scientific Director)
Joël VACUS (CEO Drugabilis)
(physico-chemistry analysis, with biotech & big pharma experience...)
Mathieu GUTMANN (LabEx LERMI, SATT Paris-Saclay)
(pharmacology vivo-vitro, CRO study management, with biotech experience)
Angelo PACI (Gustave Roussy, UMR CNRS 8203)
(pharmacology and Analysis of the Medicine department of biology and medical pathology)
Henri BENECH (CEA/DRF/JOLIOT)
(Patnership and Valorisation)